Ruano, Dina

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

de Vries, N. L., van de Haar, J., Veninga, V., Chalabi, M., Ijsselsteijn, M. E., van der Ploeg, M., van den Bulk, J., Ruano, D., van den Berg, J. G., Haanen, J. B., et al. (2023) · Nature

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 311

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

van den Bulk, J., Verdegaal, E. M. E., Ruano, D., Ijsselsteijn, M. E., Visser, M., van der Breggen, R., Duhen, T., van der Ploeg, M., de Vries, N. L., Oosting, J., et al. (2019) · Genome Medicine

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 63

A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer

Brouwer, T., Ijsselsteijn, M., Oosting, J., Ruano, D., van der Ploeg, M., Dijk, F., Bonsing, B., Fariña, A., Morreau, H., Vahrmeijer, A., et al. (2022) · Cancers

Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers

Cited by 24

Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients

Terlouw, D., Boot, A., Ducarmon, Q. R., Nooij, S., Suerink, M., van Leerdam, M. E., van Egmond, D., Tops, C. M., Zwittink, R. D., Ruano, D., et al. (2024) · BMC Cancer

Genetic factors in colorectal cancerCancer Genomics and Diagnostics

Cited by 15